课题基金 / 基金详情

Using ex vivo organotypic cultures to investigate donor cell integration in the gut

Using ex vivo organotypic cultures to investigate donor cell integration in the gut
使用离体器官型培养物研究肠道中供体细胞的整合
批准号:
NC/V001078/1
负责人:
Conor McCann
金额:
$39.31万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The correct functioning of the gut depends on the movement of the gut wall along the length of the bowel. This functional movement is coordinated by nerve cells within the gut called the enteric nervous system, or ENS for short. When there is an issue with any of these nerve cells this results in diseases called "enteric neuropathies". There are no cures for these diseases and successful treatment remains a challenge. Unfortunately, patients often have surgery to remove large pieces of gut. This can cause significant problems, as patients have to live with long-term, life changing symptoms. Therefore, new treatments for these diseases are vital.Over the past 10 years scientists have suggested that stem cells may be a good option to treat these diseases. Work from our group, and others, have shown that it is possible to rescue nerve cells in mice by transplanting gut nervous system stem cells. However, we don't really understand how these stem cells do this. One important factor is that most of these studies have performed surgery in mice and transplanted donor cells to the gut. While this has worked in showing donor stem cells can grow and function in the gut, there are a number of drawbacks. Normally, these studies use a large number of mice as it is only possible to transplant cells once. After the surgery it is also difficult to understand how the donor cells behave as it is difficult to see them inside the mouse. Recently, our group have developed a method which allows us to take some mouse gut and keep this alive in a dish for up to 3 weeks. This system allows us to get 6 segments of bowel from any 1 mouse gut. By doing this we can reduce the number of mice used in any experiment by nearly 84%. Also using this approach we don't have to do surgery on the mice anymore. As we can then grow the gut in an incubator we can transplant any cells and learn how they behave in the gut more easily. Therefore, in this study we hope to:1) Investigate how different gut nervous system stem cells move in the gut2) Determine what happens to the gut after transplantation3) Assess how gut nervous system stem cells function after transplantation.To do this, we want to use our new method to investigate how different gut nervous system stem cells behave in the gut after transplantation, while reducing the numbers of mice used. To investigate how different gut nervous system stem cells move in the gut we will first tag mouse embryonic stem cells with a marker. This marker will allow us to follow the cells after transplantation. With help from colleagues in the University of Sheffield we will then make gut nervous system stem cells which contain the marker in a dish. We will then transplant these gut nervous system stem cells to mouse gut using our new system and look at what they do over 3 weeks. We will then study how transplantation affects the gut by looking at the protein code of the gut before and after we transplant donor cells. Finally, we will look at how the donor cells work in the gut by applying a dye which allows us to record activity in individual cells. These studies will allow us to understand how different gut nervous system stem cells behave in the gut after transplantation, and what this does to the gut itself. This will be very important in helping to develop better treatments for gut diseases. However, these studies will also help to prove that our new system really works and that we can reduce the number of animals used in these types of experiment. By showing this we hope that we can encourage other scientists to use this system so that we can help to reduce the overall number of animals used in research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
ColQ基因新突变合并反式EX14-EX15缺失对先天性肌无力5型的致病作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    张晨晖
  • 依托单位:
HucMSC-Ex调控巨噬细胞FXR表达抑制铁死亡修复IBD的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    毛飞
  • 依托单位:
Sirt1 抑制剂 EX527 在 HBV 相关肝癌脂质代谢重编程中的作用及临床意义
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2024
  • 负责人:
    曹铸敏
  • 依托单位:
基于抗菌/消炎/免疫调节研究MDC@Ex-γ3-CeO2@PDA多靶点阻断和协同干预脓毒症急性肺损伤的作用及机制
  • 批准号:
    82372161
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    桂水清
  • 依托单位: